RPS19 and Diamond-Blackfan anemia: Additionally, patients with RPS19-mutated DBA are characterized by a poor response to steroids, the standard treatment for DBA (1, 37, 38), and have a poorer long-term prognosis as compared with other DBA patients (39), indicating the necessity of developing safe and efficient therapies for these patients.